Hema Tallman: Honored To Be Appointed Chair of the Global Plasma Board of PPTA
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, shared on LinkedIn:
”I have dedicated much of my career to leading large healthcare organizations, where teams collaborate daily to serve patients, pharmacists, clinicians, and communities.
A key realization I’ve come to is that the most significant challenges in healthcare cannot be addressed by any single company; they require our industry to work together.
I am honored to have been appointed Chair of the Global Plasma Board of the Plasma Protein Therapeutics Association (PPTA).
The plasma-derived therapies community exemplifies what collaboration across the healthcare ecosystem can achieve.
From plasma donors to manufacturers, healthcare providers, scientists, regulators, and, most importantly, our patients, thousands contribute to therapies that people around the world rely on every day.
Leading organizations with over 11,000 employees has imparted many lessons about leadership at scale.
One crucial lesson is that trust is not established through words but through consistent, collective action.
As trust in healthcare systems faces global challenges, the need for transparent and collaborative efforts across the industry has never been more critical.
I am grateful for the opportunity to contribute to this important work alongside my fellow board members and the broader PPTA community.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers